Home › Gilead's hepatitis C drugs largely cost-effective in US: study
 

Keywords :   


Gilead's hepatitis C drugs largely cost-effective in US: study

2015-03-17 04:45:41| Biotech - Topix.net

New hepatitis C drugs that shorten treatment times are largely cost-effective despite their hefty U.S. price tags, according to two new analyses. The widespread use of a combination of drugs that include Gilead Sciences Inc's Sovaldi, known generically as sofosbuvir, will nonetheless be a significant cost for the U.S. healthcare system, researchers wrote.

Tags: us study drugs largely

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Eastern North Pacific Tropical Weather Outlook
20.05Atlantic Tropical Weather Outlook
20.05China hits back at US and EU as trade rows deepen
20.05How should countries deal with falling birth rates?
20.05Eastern North Pacific Tropical Weather Outlook
20.05Atlantic Tropical Weather Outlook
20.05Water investors have withdrawn billions, says research
19.05Atlantic Tropical Weather Outlook
More »